US FDA to Offer Ultra-Fast Review for Psychedelic Drugs
Fast facts
- Category: Asia
- Language: EN
- Published: 2026-04-24 10:28 UTC
- Sources: South China Morning Post
The Food and Drug Administration has announced ultra-fast review for three psychedelic drugs, following a directive from President Donald Trump. The move indicates the administration's commitment to experimental treatment approaches.
Why it matters
- This update can influence the Asia agenda over the next 24-48 hours.
- It is based on 1 source, which helps cross-check key claims quickly.
- Watch follow-up statements and market/public response to assess real impact.